Mangoceuticals
MGRX
MGRX
9 hedge funds and large institutions have $440K invested in Mangoceuticals in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$278K |
| 2 |
Renaissance Technologies
New York
|
+$47.1K |
| 3 |
Goldman Sachs
New York
|
+$16.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$315 |
Top Sellers
| 1 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$13.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$11.3K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$5.63K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $278K | +$278K | +182,613 | New |
|
|
ACA
2
Ackerman Capital Advisors
Dallas,
Texas
| $52.4K | – | – | – |
|
|
3
Renaissance Technologies
New York
| $47.1K | +$47.1K | +31,000 | New |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $40.3K | +$10.5K | +6,928 | +35% |
|
|
5
Goldman Sachs
New York
| $16.1K | +$16.1K | +10,570 | New |
|
|
SPIA
6
Steward Partners Investment Advisory
New York
| $3.18K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $2.81K | +$315 | +207 | +13% |
|
8
Bank of America
Charlotte,
North Carolina
| $247 | +$224 | +148 | +987% |
|
|
9
UBS Group
Zurich,
Switzerland
| $120 | -$11.3K | -7,431 | -99% |
|
|
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$13.8K | -7,100 | Closed |
|
|
11
Osaic Holdings
Scottsdale,
Arizona
| – | -$5.63K | -2,885 | Closed |
|